CEPI Approves $4.4M In Additional Funding For Coronavirus Vaccine Research, Bringing Total To $23.7M
Reuters: Epidemic response group ups coronavirus vaccine funding to $23.7 mln
“The CEPI global epidemic response coalition said on Tuesday it will put a further $4.4 million into deals with the biotech firm Novavax and Britain’s University of Oxford to rapidly develop potential vaccines against COVID-19. The Coalition for Epidemic Preparedness Innovations (CEPI), which was set up to fight emerging epidemics, said the extra funding brought its total investment in development of new vaccines against the new coronavirus to $23.7 million…” (Kelland, 3/10).
Additional coverage of coronavirus vaccine and treatment research is available from The Guardian, Reuters, and TIME.
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.